Position in PFE
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$6,868,530
-$596,874 QoQ
Shares Held
285,238
+7.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#512
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 53%
Shared 0%
None 47%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RWA WEALTH PARTNERS, LLC holds $307,753,519 across 11 Drug Manufacturers - General names. PFE ranks #7 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
387,249 | $98,349,628 | |
| 2 | LLY |
ELI LILLY & Co
|
76,026 | $91,187,872 | |
| 3 | ABBV |
AbbVie Inc.
|
235,826 | $59,343,254 | |
| 4 | AMGN |
Amgen Inc
|
48,114 | $17,423,041 | |
| 5 | MRK |
Merck & Co., Inc.
|
111,388 | $14,313,357 | |
| 6 | AZN |
Astrazeneca PLC
|
45,390 | $8,606,851 | |
| 7 | PFE |
Pfizer Inc
This page
|
285,238 | $6,868,530 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
34,341 | $4,338,641 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,868,530 | 285,238 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $7,465,404 | 265,862 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $5,729,116 | 230,085 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,049,945 | 237,439 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $5,628,721 | 232,208 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $6,672,832 | 263,332 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $7,237,330 | 272,798 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $19,283,560 | 666,329 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $7,611,622 | 272,038 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,956,590 | 286,724 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $8,387,217 | 291,324 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $3,237,325 | 97,598 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $3,443,958 | 93,892 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $1,068,388 | 26,186 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $1,209,827 | 23,611 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $1,095,312 | 25,030 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $1,459,336 | 27,834 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $1,323,292 | 25,561 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $1,449,913 | 24,554 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $1,035,035 | 24,065 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $956,874 | 24,435 | Shares | Sole | 2021-07-09 | |
| 2021-03-31 | $902,597 | 24,913 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $927,648 | 25,201 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $6,659,135 | 181,448 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $6,218,271 | 190,161 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $6,148,029 | 188,359 | Shares | Sole | 2020-04-08 | |
| No filing history on record for this holder in this stock. | ||||||